8:55am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The short interest data are out for the July 31 settlement date, and overall, short interest in the selected biotech stocks backed off for this period.
Companies
/Healthcare
Biogen Inc
$218.50
▼ $3.00 (−1.35%) today
Markets closed · 11:45am ET
BIIB Coverage
Page 247:35am ET
Health and Healthcare
5 Top BioPharma Stocks That May Have Sold Off Too Much and Become Bargains
It may be impossible to ever know if a true bottom has ever been seen, but many investors love finding great companies where they feel that a sell-off has overly punished the…
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Adobe, Biogen, Google, PDC Energy, Rackspace, XL Group and Many More
Tuesday's top analyst upgrades, downgrades and initiations include Adobe, Biogen, Google, PDC Energy, Rackspace and XL Group.
8:20am ET
Health and Healthcare
3 Large Biotech Stocks to Buy Despite Higher Interest Rates Coming
Merrill Lynch has looked at large cap biotech leaders and how interest rate increases may play a part in stock performance.
3:44pm ET
Health and Healthcare
Will Biogen Win From Novartis MS Drug Safety Label Change?
ThinkstockThere are times when a negative piece of news in the BioPharma sector can actually help rival companies. Biogen Inc. (NASDAQ: BIIB) is a stock that has been battered of late, and…
8:35am ET
Health and Healthcare
3 Potential Huge Takeover Targets in Biotech
In a new research report, Cowen's well-respected analyst Ken Cacciatore makes a very good case that some huge, high-profile biotech companies could be targeted for buyouts.
9:05am ET
Investing
Tech and Biotech See Big-Time Insider Buying This Week – Apple, Biogen, Qualcomm and More
ThinkstockNothing like earnings season coming around to buy stock if you are an insider and your company happens to disappoint. While most of the S&P 500 companies have reported as August begins,…
8:24am ET
Investing
Top Analyst Upgrades and Downgrades: AT&T, Chesapeake, Facebook, Qualcomm, Weatherford and Many More
Jon OggStocks were indicated lower by almost 1% on Monday after China’s Shanghai market suffered its biggest loss in about 8 years on Monday. The one trend that has held up for…
7:57am ET
Health and Healthcare
Short Sellers Back Off Major Biotechs
ThinkstockThe short interest data are out for the July 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can make or…
10:21am ET
Health and Healthcare
BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead
ThinkstockPharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings from Dow Jones Industrial Average companies Merck & Co. Inc. (NYSE: MRK)…
8:25am ET
Health and Healthcare
Why Biogen Shares Are Tumbling After Earnings Report
Biogen reported mixed second-quarter 2015 results before markets opened Friday morning.
Paul Ausick 1:55pm ET
Health and Healthcare
What to Look for in Biogen Earnings Report
Biogen is scheduled to release its second-quarter financial results before the markets open on Friday.
Chris Lange 1:55pm ET
Health and Healthcare
Biogen Faces Mixed Alzheimer’s Reception
It seems Biogen's closely watched Alzheimer's drug candidate, aducanumab, has fallen short of analyst and investor expectations.
Jon C. Ogg 9:35am ET
Health and Healthcare
Top Health Care Earnings for the Week Ahead
Earnings season is hitting its stride next week, and the health care sector, the biotech stocks in particular, have been on a roll for the past 12 months.
10:50am ET
Health and Healthcare
Why Biogen Is Now a Buy on Weakness
Merrill Lynch sees Biogen returning to these heightened levels, with its pipeline acting as the primary catalyst.
Chris Lange